Virtual Medicinal Product (VMP) - Lanadelumab 300mg/2ml solution for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Lanadelumab 300mg/2ml solution for injection vials | Start Date 30-09-2019 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- B06AC05
| Code | Start Date | End Date |
|---|---|---|
| 37762611000001109 | 30-09-2019 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Lanadelumab | Based on Ingredient Substance | 150 mg | 1 ml |
Name
Lanadelumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMLanadelumab
-
VMP(Current) Lanadelumab 300mg/2ml solution for i...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |